My Nonacus
Panel Design Tool

Products
Clinical Services
Academy
- Publications
- Blog
Support
About
Contact us

Products
Clinical Services
Academy
- Publications
- Blog
Support
- Technical Documentation
- FAQs
About
Contact us

Galeas Bladder

Nonacus, the University of Birmingham and Cancer Research UK invest £5m in bladder cancer trials

By Becky Lamont / August 15, 2025 / Comments Off on Nonacus, the University of Birmingham and Cancer Research UK invest £5m in bladder cancer trials

PRODUCTS

In Vitro Diagnostic (UKCA) Products
Clinical Research (RUO) Products
Custom Panels
Collaborative Designs

Clinical Services

CLINICAL SERVICES

GALEAS Bladder
Hereditary Cancer
Hereditary Cancer Direct

Resources

RESOURCES

Technical documentation
Publications
Blog
FAQs

ABOUT

About Nonacus
Our Technology
Distributors
Careers
News & Events

Panel Design Tool

My Nonacus

Twitter

Instagram

Facebook

Sign up to receive updates

Privacy Notice
Terms and Conditions
GALEAS Terms of Use
Cookie Policy

API Terms of Use
Anti-Bribery & Corruption Policy
Modern Slavery Policy

In Vitro Diagnostic (UKCA) Products
Invitro Diagnostic (UKCA) Products
Clinical Research (RUO) Products
Clinical Research (RUO) Products
Custom Panels
Custom Panels
Collaborative Designs
Collaborative Designs

In Vitro Diagnostic (UKCA) Products

Clinical Oncology

GALEAS Bladder (UKCA)
GALEAS Tumor (UKCA)
GALEAS Hereditary (UKCA)
GALEAS uPCR: ESR1 (UKCA)

Clinical Research (RUO) Products

Targeted Panels

Whole Exome

- Nexome (RUO)
- Whole Exome (RUO)

Custom Panels

- Panel Design Tool
- Custom panels

Sample Collection

cfDNA collection tubes (RUO)

Sample Isolation

cfDNA bead-based extraction kit
cfDNA spin column extraction kit (RUO)

Custom Panels

Custom NGS panels

Panel Design Tool
Custom NGS panels
Cell3 Target Technology

Applications

Collaborative Designs

Collaborative designs

PanHemeOnc Panel
Actionable Mutation Panel
Carrier Screening Panel
Familial Hypercholesterolemia Panel

Manage Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Galeas Bladder

Nonacus, the University of Birmingham and Cancer Research UK invest £5m in bladder cancer trials

Linkedin

Twitter

Instagram

Facebook

Clinical Oncology

Targeted Panels

Whole Exome

Custom Panels

Sample Collection

Sample Isolation

Custom NGS panels

Applications

Collaborative designs